Reports

Ideas That Generate Results

List of Figures:

Figure 3-1: Worldwide - Value of Bioinformatics Market (in Million $), 2002-2005      
Figure 3-2: Worldwide - Forecast of Bioinformatics Market (in Million $), 2006-2010      
Figure 3-3: US - Bioinformatics Market (in Million $), 2002-2005      
Figure 3-4: US - Funding for the Microbial Genome Project (in Billion $), 1997-2004      
Figure 3-5: Canada - Biotechnology Firms by Sector (%), 2003   
Figure 3-6: Europe - Bioinformatics Market (in Million $), 2004-2011E   
Figure 3-7: Europe - Total R & D Funding and Drugs in Pipeline by Company Sizes (%), 2004       
Figure 3-8: Asia Pacific - Bioinformatics Market (in Million $), 2002-2005      
Figure 3-9: Worldwide - Bioinformatics Market Segments (%), 2005   
Figure 3-10: Worldwide - Analysis Software and Services Market (in Million $), 2005-2010E   
Figure 3-11: Worldwide - Analytical Software Market Segmentation (%), 2004       
Figure 3-12: Worldwide - Analytical Software Market by Region (%), 2004
Figure 3-13: Worldwide - Content Market (in Million $), 2005-2010E
Figure 3-14: Worldwide - Market Segmentation by Application Area (%), 2001   
Figure 3-15: Worldwide - Genomics Market (in Billion $), 2000, 2002, 2004, 2006E, 2008E & 2010E 
Figure 3-16: Worldwide - DNA Sequencing and Proteomics Market (in Billion $), 2004-2009E   
Figure 3-17: Worldwide - Forecast of Pharmacogenomics Market (in Million $), 2006-2009      
Figure 3-18: Worldwide - Drug Discovery Expenditure (in Billion $), 2002 & 2006           
Figure 3-19: Worldwide - Revenues for Selected Drug Discovery Related Products (in Million $), 2000 & 2005  
Figure 4-1: US - R & D Spending (%), 2001   
Figure 6-1: Accelrys, Inc. - Stock Performance    
Figure 6-2: Affymetrix, Inc. - Stock Performance    
Figure 6-3: Agilent Technologies, Inc. - Stock Performance    
Figure 6-4: Applied Biosystems Group - Stock Performance
Figure 6-5: Celera Genomics Group - Stock Performance
Figure 6-6: Ciphergen Biosystems - Stock Performance
Figure 6-7: Compugen Ltd. - Stock Performance    
Figure 6-8: CuraGen Corporation - Stock Performance    
Figure 6-9: Gene Logic Inc. - Stock Performance    
Figure 6-10: IBM Life Sciences - Stock Performance    
Figure 6-11: Incyte Corporation - Stock Performance    
Figure 6-12: LION Bioscience AG - Stock Performance
Figure 6-13: Silicon Graphics, Inc. - Stock Performance    
Figure 6-14: Tripos, Inc. - Stock Performance     

List of Tables:

Table 3-1: Worldwide - Growth in Key Bioinformatics Databases (Dec. 2004 & Dec. 2005)      
Table 3-2: Worldwide - Pharmacogenomics Market (in Million $), 2001-2004      
Table 6-1: Accelrys, Inc. - Annual Income Statements (in Million US $), Dec. 2003, Mar. 2005 & Mar. 2006       
Table 6-2: Affymetrix, Inc. - Annual Income Statements (in Million US $), 2003-2005      
Table 6-3: Agilent Technologies, Inc. - Annual Income Statements (in Million US $), 2003-2005      
Table 6-4: Agilent Technologies, Inc. - Bioanalytical Measurement Net Revenue (in Million US $), 2003-2005
Table 6-5: Applied Biosystems Group - Annual Income Statements (in Million US $), 2003-2005      
Table 6-6: Celera Genomics Group - Annual Income Statements (in Million US $), 2003-2005   
Table 6-7: Ciphergen Biosystems - Annual Income Statements (in Million US $), 2003-2005      
Table 6-8: Compugen Ltd. - Annual Income Statements (in Million US $), 2003-2005      
Table 6-9: CuraGen Corporation - Annual Income Statements (in Million US $), 2003-2005      
Table 6-10: Gene Logic Inc. - Annual Income Statements (in Million US $), 2003-2005      
Table 6-11: IBM Life Sciences - Annual Income Statements (in Million US $), 2003-2005      
Table 6-12: Incyte Corporation - Annual Income Statements (in Million US $), 2003-2005      
Table 6-13: LION Bioscience AG - Annual Income Statements (in Million Euro), 2003-04 & 2004-05          
Table 6-14: Silicon Graphics, Inc. - Annual Income Statements (in Million US $), 2003-2005      
Table 6-15: Tripos, Inc. - Annual Income Statements (in Million US $), 2003-2005